DLA Piper Denmark advises the sellers of Visiopharm on the sale to Grundium
DLA Piper Denmark has advised the sellers of Visiopharm, a leading provider of AI driven digital pathology solutions, on the sale of the company to the Finnish life science company Grundium, backed by private equity fund EW Healthcare.
Visiopharm is a leading provider of AI driven precision pathology software for research, diagnostics and biopharmaceutical services. In research, the company provides tools that help scientists, pathologists and image analysis experts produce accurate data across all types of tissue based research. Visiopharm operates internationally with more than 750 customer accounts in over 40 countries.
Grundium is a global leader in digital pathology imaging technology, advancing access to digital pathology through slide scanning solutions designed for demanding professional workflows. Grundium develops compact, high quality digital pathology scanners for healthcare, education and research environments, combining advanced technology with intuitive usability and exceptional design.
The transaction represents a significant milestone for Visiopharm and supports the company’s continued international growth and development within digital pathology and precision diagnostics. By joining forces with Grundium and EW Healthcare Partners, Visiopharm is well positioned to further strengthen its technological platform, expand its global footprint and accelerate innovation.
We have represented all sellers throughout a highly complex, multi jurisdictional process, which required close coordination across several DLA Piper offices, including Finland, the United States and Sweden. The transaction involved a broad range of legal disciplines and cross border considerations, reflecting both the international nature of the business and the strategic importance of the transaction.
Visiopharm has been a valued client of ours since 2012, and advising on this transaction marks the culmination of a long standing and trusted relationship.
The core transaction team was led by Peter Bruun Nikolajsen, Patrick Andersen and Bahja Kulane, supported by a dedicated cross border team from DLA Piper.
